Key facts
- Neurobit Technologies (Diagnostic Equipment)’s last known valuation is $3.6M (Aug 2021).
- It has raised $1.0M; the latest was Later Stage VC in Mar 2025.
- Notable investors include Microsoft for Startups, National Development Fund of Taiwan, Be Health Ventures, RAPID-Health, Taipei Medical University — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Neurobit Technologies (Diagnostic Equipment)
- ·The full record, as it builds
Funding rounds
No funding rounds for Neurobit Technologies (Diagnostic Equipment) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Neurobit Technologies (Diagnostic Equipment)
Manufacturer of a complete neuro-otological diagnostic device intended to solve unmet neuro-clinical needs. The company offers video-oculography services for neurological disorders, a comprehensive neuro-functional digital diagnostic system, early high-risk brain disorders detection, and assisted diagnosis, enabling professionals, patients, and insurance companies to reduce the medical burden of disease.
- Sector
- Healthcare
- HQ
- Taipei City, Taiwan
- Founded
- 2016
- Website
- neurobittech.com/
- Ownership
- Privately Held (backing)
Neurobit Technologies (Diagnostic Equipment) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Neurobit Technologies (Diagnostic Equipment) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Neurobit Technologies (Diagnostic Equipment) in its N-PORT filings yet. We sweep new filings monthly.